XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative effect adjustment
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Cumulative effect adjustment
Beginning balance (in shares) at Jun. 30, 2019     144,433          
Beginning balance at Jun. 30, 2019 $ 4,673,865 $ 3,018 $ 144 $ 6,409,405 $ (11,602,573) $ (64,030) $ 9,930,919 $ 3,018
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)     1,230          
Issuance of common stock 6,215   $ 1 6,214        
Purchase of treasury stock (in shares)     (5,215)          
Purchase of treasury stock (1,328,898)   $ (4)   (1,328,894)      
Reissuance of treasury stock (in shares)     296          
Reissuance of treasury stock 38,447     25,710 12,737      
Equity-based compensation expense 136,044     136,044        
Effect of conversion of convertible notes (in shares)     4,412          
Effect of conversion of convertible notes (37,440)   $ 4 (37,444)        
Reclassification from temporary to permanent equity 37,893     37,893        
Net income 1,555,080           1,555,080  
Other comprehensive income (loss) (48,646)         (48,646)    
Cash dividends declared (497,971)           (497,971)  
Ending balance (in shares) at Mar. 29, 2020     145,156          
Ending balance at Mar. 29, 2020 4,537,607   $ 145 6,577,822 (12,918,730) (112,676) 10,991,046  
Beginning balance (in shares) at Dec. 29, 2019     142,462          
Beginning balance at Dec. 29, 2019 4,379,429   $ 142 6,528,821 (12,673,292) (60,247) 10,584,005  
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)     1,047          
Issuance of common stock 1,714   $ 1 1,713        
Purchase of treasury stock (in shares)     (1,576)          
Purchase of treasury stock (245,439)   $ (1)   (245,438)      
Equity-based compensation expense 47,414     47,414        
Effect of conversion of convertible notes (in shares)     3,223          
Effect of conversion of convertible notes (26,881)   $ 3 (26,884)        
Reclassification from temporary to permanent equity 26,758     26,758        
Net income 574,781           574,781  
Other comprehensive income (loss) (52,429)         (52,429)    
Cash dividends declared (167,740)           (167,740)  
Ending balance (in shares) at Mar. 29, 2020     145,156          
Ending balance at Mar. 29, 2020 4,537,607   $ 145 6,577,822 (12,918,730) (112,676) 10,991,046  
Beginning balance (in shares) at Jun. 28, 2020     145,331          
Beginning balance at Jun. 28, 2020 5,172,494 [1] $ 1,157 [2] $ 145 6,695,858 (12,949,889) (94,211) 11,520,591 $ 1,157 [2]
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)     1,053          
Issuance of common stock 23,272   $ 1 23,271        
Purchase of treasury stock (in shares)     (4,887)          
Purchase of treasury stock (2,272,222)   $ (4)   (2,272,218)      
Reissuance of treasury stock (in shares)     207          
Reissuance of treasury stock 41,434     32,261 9,173      
Equity-based compensation expense 163,843     163,843        
Effect of conversion of convertible notes (in shares)     903          
Effect of conversion of convertible notes (987)   $ 1 (988)        
Reclassification from temporary to permanent equity 7,778     7,778        
Net income 2,763,801           2,763,801  
Other comprehensive income (loss) 30,914         30,914    
Cash dividends declared (559,868)           (559,868)  
Ending balance (in shares) at Mar. 28, 2021     142,607          
Ending balance at Mar. 28, 2021 5,371,616   $ 143 6,922,023 (15,212,934) (63,297) 13,725,681  
Beginning balance (in shares) at Dec. 27, 2020     143,205          
Beginning balance at Dec. 27, 2020 5,503,033   $ 143 6,854,681 (14,135,555) (56,126) 12,839,890  
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)     848          
Issuance of common stock 9,626   $ 1 9,625        
Purchase of treasury stock (in shares)     (1,731)          
Purchase of treasury stock (1,077,380)   $ (1)   (1,077,379)      
Equity-based compensation expense 55,746     55,746        
Effect of conversion of convertible notes (in shares)     285          
Effect of conversion of convertible notes (327)     (327)        
Reclassification from temporary to permanent equity 2,298     2,298        
Net income 1,071,121           1,071,121  
Other comprehensive income (loss) (7,171)         (7,171)    
Cash dividends declared (185,330)           (185,330)  
Ending balance (in shares) at Mar. 28, 2021     142,607          
Ending balance at Mar. 28, 2021 $ 5,371,616   $ 143 $ 6,922,023 $ (15,212,934) $ (63,297) $ 13,725,681  
[1] Derived from audited financial statements
[2] (1) Refer to Note 2 - Recent Accounting Pronouncements for more information regarding this Financial Accounting Standards Board (FASB) Accounting Standard Updates.